These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 22178315

  • 1. Effects of calcium channel antagonists on the motivational effects of nicotine and morphine in conditioned place aversion paradigm.
    Budzynska B, Polak P, Biala G.
    Behav Brain Res; 2012 Mar 01; 228(1):144-50. PubMed ID: 22178315
    [Abstract] [Full Text] [Related]

  • 2. Reinstatement of nicotine-conditioned place preference by drug priming: effects of calcium channel antagonists.
    Biala G, Budzynska B.
    Eur J Pharmacol; 2006 May 10; 537(1-3):85-93. PubMed ID: 16616917
    [Abstract] [Full Text] [Related]

  • 3. Development, extinction and reinstatement of morphine withdrawal-induced conditioned place aversion in rats.
    Li Y, Liu X, Chen H, Deng H, Xiang X, Chen H, Hao W.
    Addict Biol; 2007 Sep 10; 12(3-4):470-7. PubMed ID: 17678507
    [Abstract] [Full Text] [Related]

  • 4. Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion.
    Guillem K, Vouillac C, Koob GF, Cador M, Stinus L.
    Biol Psychiatry; 2008 Jan 15; 63(2):158-63. PubMed ID: 17643399
    [Abstract] [Full Text] [Related]

  • 5. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L, Cador M, Zorrilla EP, Koob GF.
    Neuropsychopharmacology; 2005 Jan 15; 30(1):90-8. PubMed ID: 15138444
    [Abstract] [Full Text] [Related]

  • 6. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
    Azar MR, Jones BC, Schulteis G.
    Psychopharmacology (Berl); 2003 Oct 15; 170(1):42-50. PubMed ID: 12783156
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine.
    Popik P, Danysz W.
    J Pharmacol Exp Ther; 1997 Feb 15; 280(2):854-65. PubMed ID: 9023300
    [Abstract] [Full Text] [Related]

  • 8. Adolescent nicotine exposure produces less affective measures of withdrawal relative to adult nicotine exposure in male rats.
    O'Dell LE, Torres OV, Natividad LA, Tejeda HA.
    Neurotoxicol Teratol; 2007 Feb 15; 29(1):17-22. PubMed ID: 17184972
    [Abstract] [Full Text] [Related]

  • 9. Nicotine attenuates place aversion induced by naloxone in single-dose, morphine-treated rats.
    Araki H, Kawakami KY, Jin C, Suemaru K, Kitamura Y, Nagata M, Futagami K, Shibata K, Kawasaki H, Gomita Y.
    Psychopharmacology (Berl); 2004 Feb 15; 171(4):398-404. PubMed ID: 13680070
    [Abstract] [Full Text] [Related]

  • 10. Calcium channel antagonists suppress nicotine-induced place preference and locomotor sensitization in rodents.
    Biała G.
    Pol J Pharmacol; 2003 Feb 15; 55(3):327-35. PubMed ID: 14506311
    [Abstract] [Full Text] [Related]

  • 11. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
    Jin C, Araki H, Nagata M, Shimosaka R, Shibata K, Suemaru K, Kawasaki H, Gomita Y.
    Behav Brain Res; 2005 Jun 03; 161(1):107-12. PubMed ID: 15904717
    [Abstract] [Full Text] [Related]

  • 12. Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal.
    Göktalay G, Cavun S, Levendusky MC, Hamilton JR, Millington WR.
    Eur J Pharmacol; 2006 Jan 13; 530(1-2):95-102. PubMed ID: 16364288
    [Abstract] [Full Text] [Related]

  • 13. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.
    Rezayof A, Nazari-Serenjeh F, Zarrindast MR, Sepehri H, Delphi L.
    Eur J Pharmacol; 2007 May 07; 562(1-2):92-102. PubMed ID: 17336285
    [Abstract] [Full Text] [Related]

  • 14. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S, Göktalay G, Millington WR.
    J Pharmacol Exp Ther; 2005 Nov 07; 315(2):949-58. PubMed ID: 16079299
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Calcium channel antagonists attenuate cross-sensitization to the rewarding and/or locomotor effects of nicotine, morphine and MK-801.
    Biala G, Weglinska B.
    J Pharm Pharmacol; 2004 Aug 07; 56(8):1021-8. PubMed ID: 15285847
    [Abstract] [Full Text] [Related]

  • 18. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
    Haghparast A, Khani A, Naderi N, Alizadeh AM, Motamedi F.
    Pharmacol Biochem Behav; 2008 Feb 07; 88(4):385-92. PubMed ID: 17915302
    [Abstract] [Full Text] [Related]

  • 19. On the mechanism of cross-tolerance between morphine- and nicotine-induced antinociception: involvement of calcium channels.
    Biala G, Weglinska B.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan 07; 30(1):15-21. PubMed ID: 16202496
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.